- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0137961

Everlive Pharma Private Limited
About Everlive Pharma Private Limited
Data last updated:
Everlive Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the manufacturing segment of the jewellery and fashion accessories sector. It was incorporated on 07 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33302TN2018PTC123099. Its GSTIN is 32AAFCE0808G1Z6 (Kerala).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Anish Anamala Akbar (Managing Director) and Mohammed Sirajudeen Aathikka Begam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1 & 1A Ur Nagar Extn, Anna Nagar West Extn Chennai, Tamil Nadu, India – 600050.
As per the financials filed for FY 2024, the company reported a revenue of ₹87.09 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Lakh (net margin 1.3%) and EBITDA of ₹2.41 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 36% over five years.
Everlive Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0137961).
Company details
Recognitions & Rankings of Everlive Pharma
Contact details
Everlive Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address1 & 1A Ur Nagar Extn, Anna Nagar West Extn Chennai, Tamil Nadu, India – 600050
- IndustryJewelry & Fashion Accessories, Manufacturing, Watches And Clocks
To see the full contact details of Everlive Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Everlive Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Everlive Pharma Private Limited, buy the company report.
Financials of Everlive Pharma Private Limited
FY 2024 filings availableEverlive Pharma Private Limited reported revenue of ₹87.09 Lakh (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 17% growth in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Everlive Pharma Private Limited, buy the company report.
Board of directors of Everlive Pharma Private Limited
Everlive Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anish Anamala Akbar | Managing Director | 07 Jun 2018 | 8 Years 5 Months | Current |
| Mohammed Sirajudeen Aathikka Begam | Director | 10 Jul 2024 | 2 Years 4 Months | Current |
| Sherin Ameer | Director | 10 Jul 2024 | 2 Years 4 Months | Current |
Peer comparison
Everlive Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auto Luxe India Private Limited | ₹87.12 Lakh (FY 2025) | 43.0% | Surat, Gujarat, India | |||
| Skiskin (OPC) Private Limited | ₹87.11 Lakh (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Fusion Trading Company Private Limited | ₹87.1 Lakh (FY 2015) | -12.0% | New Delhi, Delhi, India | |||
| Diptitextech Private Limited | ₹87.09 Lakh (FY 2024) | 1173.0% | Delhi, India | |||
| Suffire Ekart Private Limited | ₹87.09 Lakh (FY 2024) | 39.0% | Delhi, India | |||
| Everlive Pharma Private Limitedthis company | ₹87.09 Lakh (FY 2024) | ₹1.12 Lakh | 1.3% | 17.0% | Chennai, Tamil Nadu, India | |
| Shrihan Communications Private Limited | ₹87.07 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Meruhi Innovations Private Limited | ₹87.07 Lakh (FY 2021) | 579.0% | Bengaluru, Karnataka, India | |||
| Brenlic Investments Private Limited. | ₹87.01 Lakh (FY 2024) | 102.0% | Tiswadi, Goa, India | |||
| Aeroheight Marketing Private Limited | ₹86.97 Lakh (FY 2016) | 17.0% | Kolkata, West Bengal, India | |||
| Pearlscart Jewellery Private Limited | ₹86.96 Lakh (FY 2016) | 33.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Everlive Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Everlive Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Everlive Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Everlive Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCE0808G1Z6 | Kerala | Active | 13 Jul 2018 |
To see the full GST registrations and return filing status of Everlive Pharma Private Limited, buy the company report.
Recent activity
Everlive Pharma Private Limited has 7 board changes on record since 2018: 3 appointments and 4 cessations. The latest: Mohammed Sirajudeen Aathikka Begam ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Everlive Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in manufacturing, within the jewelry and fashion accessories industry. It was incorporated on 07 June 2018 (8+ years old) and is registered under CIN U33302TN2018PTC123099.
Everlive Pharma has 3 current directors:
- Anish Anamala Akbar - Managing Director
- Mohammed Sirajudeen Aathikka Begam - Director
- Sherin Ameer - Director
The latest financial statements of Everlive Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Everlive Pharma is 32AAFCE0808G1Z6, registered in Kerala.
The CIN (Corporate Identification Number) of Everlive Pharma is U33302TN2018PTC123099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Everlive Pharma was incorporated on 07 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Everlive Pharma by revenue are Auto Luxe India Private Limited, Skiskin (OPC) Private Limited, Fusion Trading Company Private Limited, Diptitextech Private Limited, Suffire Ekart Private Limited and 5 more, all in the same principal business activity (retail trading).
Mohammed Sirajudeen Aathikka Begam ceased to be Additional Director on 29 Sep 2024. Sherin Ameer ceased to be Additional Director on 29 Sep 2024. Mohammed Sirajudeen Aathikka Begam was appointed as Director on 10 Jul 2024. Everlive Pharma has 7 board changes on record in total.
Yes, Everlive Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0137961).
The registered office of Everlive Pharma is at 1 & 1A Ur Nagar Extn, Anna Nagar West Extn Chennai, Tamil Nadu, India – 600050.
Everlive Pharma operates in the jewelry and fashion accessories industry, in the manufacturing segment.

